Philippe Barthélémy

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Nizar M. Tannir, Osvaldo Arén Frontera et al. · New England Journal of Medicine · 2018 · 4.6K citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial

Laurence Albigès, Nizar M. Tannir, Mauricio Burotto et al. · ESMO Open · 2020 · 522 citations · Full text

Medicine, Oncology, Pharmacology +17

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Kim N., Dana E. Rathkopf, Matthew R. Smith et al. · Journal of Clinical Oncology · 2023 · 319 citations · Full text

Medicine, Oncology, Urology +17

Real-Time PCR Assay for Rapid and Accurate Detection of Point Mutations Conferring Resistance to Clarithromycin in <i>Helicobacter pylori</i>

Mónica Oleastro, Armelle Ménard, Adriana Santos et al. · Journal of Clinical Microbiology · 2003 · 225 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +17

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial

Robert J. Motzer, Bernard Escudier, David F. McDermott et al. · Journal for ImmunoTherapy of Cancer · 2020 · 225 citations · Full text

Medicine, Oncology, Pharmacotherapy +16